Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Midkine (MK) is a heparin-binding growth factor and cytokine involved in development, tissue repair, and tumorigenesis. It promotes cell proliferation, migration, angiogenesis, and survival signaling. Overexpression is observed in various cancers, making it a potential therapeutic target. It interacts with multiple receptors including PTPζ, LRP1, integrins, ALK, and syndecans.
Inhibition of Midkine signaling via antibodies, small molecule inhibitors of its receptors (e.g., PTPζ inhibitors), or interfering with heparin binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Midkine (MK).